Available Technology

CNS Therapeutics That Target Neuronal Ceroid-Lipofuscinoses and Thioesterase Deficiency Disorders

The Eunice Kennedy Shriver National Institute of Child Health and Human Development seeks licensing or co-development partners for therapeuctic compounds to treat lysomal storage disorders.
Benefits: 
• First of its kind to treat INCL and other LSD • Non-toxic dertivative therapeutic against thioesterase deficiency disorders
applications: 
Inventors: 
Anil Mukherjee
Internal Laboratory Ref #: 
E-157-2011
Lab Representatives
Share to Facebook Share to Twitter Share to Google Plus Share to Linkedin